Equity MRK
Thursday, November 22, 2018 4:01:00 PM  
Adani Ports  367.15    (1.73%)
 
Asian Paints  1313.00    (-0.75%)
 
Axis Bank  614.30    (-1.92%)
 
Bajaj Auto  2594.10    (-0.36%)
 
Bharti Airtel  327.95    (-1.15%)
 
Coal India  256.75    (-1.61%)
 
H D F C  1869.50    (0.09%)
 
HDFC Bank  2005.45    (-0.70%)
 
Hero Motocorp  2910.00    (-0.34%)
 
Hind. Unilever  1670.50    (-1.15%)
 
ICICI Bank  351.95    (-1.36%)
 
IndusInd Bank  1529.15    (-1.16%)
 
Infosys  620.45    (-0.08%)
 
ITC  280.45    (-0.21%)
 
Kotak Mah. Ban...  1171.85    (-0.42%)
 
Larsen & Toubr...  1409.35    (0.49%)
 
M & M  745.75    (-3.02%)
 
Maruti Suzuki  7409.95    (-0.08%)
 
NTPC  146.10    (-1.18%)
 
O N G C  152.20    (0.30%)
 
Power Grid Cor...  179.95    (-1.59%)
 
Reliance Inds.  1102.85    (-0.85%)
 
St Bk of India  282.60    (-1.38%)
 
Sun Pharma.Ind...  525.80    (-1.01%)
 
Tata Motors  182.25    (-1.03%)
 
Tata Motors-DV...  98.75    (-1.30%)
 
Tata Steel  539.95    (-2.28%)
 
TCS  1815.25    (0.19%)
 
Vedanta  199.65    (-1.09%)
 
Wipro  307.45    (-2.10%)
 
Yes Bank  195.55    (-1.24%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA
(13:08, 12 Jul 2018)
Cadila Healthcare announced that the manufacturing facility of Zydus Hopsira Oncology, a 50:50 joint venture company between Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group) at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA which concluded that the inspection is closed and states that theinspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from 5 to 12 April, 2018.

Powered by Capital Market - Live News